The latest study on Spinal Muscular Atrophy Medicine Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Spinal Muscular Atrophy Medicine Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Spinal Muscular Atrophy Medicine and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Astellas Pharma Inc.
AveXis, Inc.
Bioblast Pharma Ltd.
Cytokinetics, Inc. 24
F. Hoffmann-La Roche Ltd.
Genethon
Genzyme Corporation
GMP-Orphan SAS
Ionis Pharmaceuticals, Inc.
Longevity Biotech, Inc
Neurodyn Inc.
Neurotune AG
Novartis AG
Sarepta Therapeutics, Inc.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.
Spinal Muscular Atrophy Medicine Market Analysis By Type Segment:
LMI-070
ND-602
NT-1654
Nusinersen
NXD-30001
Others
Spinal Muscular Atrophy Medicine Market Analysis By Application Segment:
Hospital
Clinic
Others
Spinal Muscular Atrophy Medicine Market Analysis By Regions (Countries):
The Spinal Muscular Atrophy Medicine Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Spinal Muscular Atrophy Medicine Report:
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Spinal Muscular Atrophy Medicine Market:
Spinal Muscular Atrophy Medicine market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Spinal Muscular Atrophy Medicine Market
What is the expected Market size and growth rate of the Spinal Muscular Atrophy Medicine market for the forecast period
Where is the largest and fastest growing market for Spinal Muscular Atrophy Medicine market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Spinal Muscular Atrophy Medicine market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Spinal Muscular Atrophy Medicine Market status and future forecast.
To present the key Spinal Muscular Atrophy Medicine Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Spinal Muscular Atrophy Medicine Market Size Growth Rate by Type (2021-2027)
1.3.2 LMI-070
1.3.3 ND-602
1.3.4 NT-1654
1.3.5 Nusinersen
1.3.6 NXD-30001
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Spinal Muscular Atrophy Medicine Market Share by Application (2021-2027)
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Medicine Market Size
2.1.1 Global Spinal Muscular Atrophy Medicine Revenue 2016-2027
2.1.2 Global Spinal Muscular Atrophy Medicine Sales 2016-2027
2.2 Spinal Muscular Atrophy Medicine Growth Rate by Regions
2.2.1 Global Spinal Muscular Atrophy Medicine Sales by Regions 2016-2020
2.2.2 Global Spinal Muscular Atrophy Medicine Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Spinal Muscular Atrophy Medicine Sales by Manufacturers
3.1.1 Spinal Muscular Atrophy Medicine Sales by Manufacturers 2016-2020
3.1.2 Spinal Muscular Atrophy Medicine Sales Market Share by Manufacturers 2016-2020
3.2 Revenue by Manufacturers
3.2.1 Spinal Muscular Atrophy Medicine Revenue by Manufacturers (2016-2020)
3.2.2 Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers (2016-2020)
3.2.3 Global Spinal Muscular Atrophy Medicine Market Concentration Ratio (CR5 and HHI)
3.3 Spinal Muscular Atrophy Medicine Price by Manufacturers
3.4 Key Manufacturers Spinal Muscular Atrophy Medicine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Spinal Muscular Atrophy Medicine Market
3.6 Key Manufacturers Spinal Muscular Atrophy Medicine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 LMI-070 Sales and Revenue (2016-2020)
4.1.2 ND-602 Sales and Revenue (2016-2020)
4.1.3 NT-1654 Sales and Revenue (2016-2020)
4.1.4 Nusinersen Sales and Revenue (2016-2020)
4.1.5 NXD-30001 Sales and Revenue (2016-2020)
4.1.6 Others Sales and Revenue (2016-2020)
4.2 Global Spinal Muscular Atrophy Medicine Sales Market Share by Type
4.3 Global Spinal Muscular Atrophy Medicine Revenue Market Share by Type
4.4 Spinal Muscular Atrophy Medicine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Spinal Muscular Atrophy Medicine Sales by Application
6 United States
6.1 United States Spinal Muscular Atrophy Medicine Breakdown Data by Company
6.2 United States Spinal Muscular Atrophy Medicine Breakdown Data by Type
6.3 United States Spinal Muscular Atrophy Medicine Breakdown Data by Application
7 European Union
7.1 European Union Spinal Muscular Atrophy Medicine Breakdown Data by Company
7.2 European Union Spinal Muscular Atrophy Medicine Breakdown Data by Type
7.3 European Union Spinal Muscular Atrophy Medicine Breakdown Data by Application
8 China
8.1 China Spinal Muscular Atrophy Medicine Breakdown Data by Company
8.2 China Spinal Muscular Atrophy Medicine Breakdown Data by Type
8.3 China Spinal Muscular Atrophy Medicine Breakdown Data by Application
9 Rest of World
9.1 Rest of World Spinal Muscular Atrophy Medicine Breakdown Data by Company
9.2 Rest of World Spinal Muscular Atrophy Medicine Breakdown Data by Type
9.3 Rest of World Spinal Muscular Atrophy Medicine Breakdown Data by Application
9.4 Rest of World Spinal Muscular Atrophy Medicine Breakdown Data by Countries
9.4.1 Rest of World Spinal Muscular Atrophy Medicine Sales by Countries
9.4.2 Rest of World Spinal Muscular Atrophy Medicine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Astellas Pharma Inc.
10.1.1 Astellas Pharma Inc. Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.1.4 Spinal Muscular Atrophy Medicine Product Introduction
10.1.5 Astellas Pharma Inc. Recent Development
10.2 AveXis, Inc.
10.2.1 AveXis, Inc. Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.2.4 Spinal Muscular Atrophy Medicine Product Introduction
10.2.5 AveXis, Inc. Recent Development
10.3 Bioblast Pharma Ltd.
10.3.1 Bioblast Pharma Ltd. Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.3.4 Spinal Muscular Atrophy Medicine Product Introduction
10.3.5 Bioblast Pharma Ltd. Recent Development
10.4 Cytokinetics, Inc. 24
10.4.1 Cytokinetics, Inc. 24 Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.4.4 Spinal Muscular Atrophy Medicine Product Introduction
10.4.5 Cytokinetics, Inc. 24 Recent Development
10.5 F. Hoffmann-La Roche Ltd.
10.5.1 F. Hoffmann-La Roche Ltd. Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.5.4 Spinal Muscular Atrophy Medicine Product Introduction
10.5.5 F. Hoffmann-La Roche Ltd. Recent Development
10.6 Genethon
10.6.1 Genethon Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.6.4 Spinal Muscular Atrophy Medicine Product Introduction
10.6.5 Genethon Recent Development
10.7 Genzyme Corporation
10.7.1 Genzyme Corporation Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.7.4 Spinal Muscular Atrophy Medicine Product Introduction
10.7.5 Genzyme Corporation Recent Development
10.8 GMP-Orphan SAS
10.8.1 GMP-Orphan SAS Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.8.4 Spinal Muscular Atrophy Medicine Product Introduction
10.8.5 GMP-Orphan SAS Recent Development
10.9 Ionis Pharmaceuticals, Inc.
10.9.1 Ionis Pharmaceuticals, Inc. Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.9.4 Spinal Muscular Atrophy Medicine Product Introduction
10.9.5 Ionis Pharmaceuticals, Inc. Recent Development
10.10 Longevity Biotech, Inc
10.10.1 Longevity Biotech, Inc Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Spinal Muscular Atrophy Medicine
10.10.4 Spinal Muscular Atrophy Medicine Product Introduction
10.10.5 Longevity Biotech, Inc Recent Development
10.11 Neurodyn Inc.
10.12 Neurotune AG
10.13 Novartis AG
10.14 Sarepta Therapeutics, Inc.
10.15 Voyager Therapeutics, Inc.
10.16 Vybion, Inc.
10.17 WAVE Life Sciences Ltd.
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Spinal Muscular Atrophy Medicine Sales Channels
11.2.2 Spinal Muscular Atrophy Medicine Distributors
11.3 Spinal Muscular Atrophy Medicine Customers
12 Market Forecast
12.1 Global Spinal Muscular Atrophy Medicine Sales and Revenue Forecast 2021-2027
12.2 Global Spinal Muscular Atrophy Medicine Sales Forecast by Type
12.3 Global Spinal Muscular Atrophy Medicine Sales Forecast by Application
12.4 Spinal Muscular Atrophy Medicine Forecast by Regions
12.4.1 Global Spinal Muscular Atrophy Medicine Sales Forecast by Regions 2021-2027
12.4.2 Global Spinal Muscular Atrophy Medicine Revenue Forecast by Regions 2021-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Spinal Muscular Atrophy Medicine Product Picture
Table Spinal Muscular Atrophy Medicine Key Market Segments
Table Major Manufacturers Spinal Muscular Atrophy Medicine Covered in This Report
Table Global Spinal Muscular Atrophy Medicine Market Size Growth Rate by Type 2021-2027 (K Pcs) & (Million US$)
Figure Global Spinal Muscular Atrophy Medicine Sales Market Shar by Type 2016-2027
Figure LMI-070 Figures
Table Major Manufacturers of LMI-070
Figure ND-602 Figures
Table Major Manufacturers of ND-602
Figure NT-1654 Figures
Table Major Manufacturers of NT-1654
Figure Nusinersen Figures
Table Major Manufacturers of Nusinersen
Figure NXD-30001 Figures
Table Major Manufacturers of NXD-30001
Figure Others Figures
Table Major Manufacturers of Others
Table Global Spinal Muscular Atrophy Medicine Market Share by Application 2021-2027 (K Pcs)
Figure Hospital Use Case
Figure Clinic Use Case
Figure Others Use Case
Figure Spinal Muscular Atrophy Medicine Report Years Considered
Figure Global Spinal Muscular Atrophy Medicine Market Size 2016-2027 (Million US$)
Figure Global Spinal Muscular Atrophy Medicine Sales 2016-2020 (K Pcs)
Table Global Spinal Muscular Atrophy Medicine Market Size by Regions 2016-2020 (K Pcs) & (Million US$)
Table Global Spinal Muscular Atrophy Medicine Sales by Regions 2016-2020 (K Pcs)
Table Global Spinal Muscular Atrophy Medicine Sales Market Share by Regions 2016-2020
Figure Global Spinal Muscular Atrophy Medicine Sales Market Share by Regions 2016-2020
Figure Global Spinal Muscular Atrophy Medicine Sales Market Share by Regions in 2020
Table Global Spinal Muscular Atrophy Medicine Revenue by Regions 2016-2020 (Million US$)
Table Global Spinal Muscular Atrophy Medicine Revenue Market Share by Regions 2016-2020
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share by Regions 2016-2020
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Spinal Muscular Atrophy Medicine Sales by Manufacturers (2016-2020) (K Pcs)
Table Global Spinal Muscular Atrophy Medicine Sales Share by Manufacturers (2016-2020)
Figure Global Spinal Muscular Atrophy Medicine Sales Share by Manufacturers in 2020
Table Spinal Muscular Atrophy Medicine Revenue by Manufacturers (2016-2020) (Million USD)
Table Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers (2016-2020)
Figure Spinal Muscular Atrophy Medicine Value Share by Manufacturers in 2020
Table Global Spinal Muscular Atrophy Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Spinal Muscular Atrophy Medicine Price (2016-2020) (USD/Pcs)
Table Key Manufacturers Spinal Muscular Atrophy Medicine Plants/Factories Distribution
Table Key Manufacturers Spinal Muscular Atrophy Medicine Area Served
Table Date of Key Manufacturers Enter into Spinal Muscular Atrophy Medicine Market
Table Key Manufacturers Spinal Muscular Atrophy Medicine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global LMI-070 Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global ND-602 Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global NT-1654 Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global Nusinersen Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global NXD-30001 Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global Others Sales and Revenue (2016-2020) (K Pcs) & (Million US$)
Table Global Spinal Muscular Atrophy Medicine Sales by Type (2016-2020) (K Pcs)
Table Global Spinal Muscular Atrophy Medicine Sales Share by Type (2016-2020)
Figure Global Spinal Muscular Atrophy Medicine Sales Market Share by Type (2016-2020)
Figure Global Spinal Muscular Atrophy Medicine Sales Market Share by Type in 2020
Table Global Spinal Muscular Atrophy Medicine Revenue by Type (2016-2020) (Million US$)
Table Global Spinal Muscular Atrophy Medicine Revenue Share by Type (2016-2020)
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share by Type (2016-2020)
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share by Type in 2020
Table Spinal Muscular Atrophy Medicine Price by Type 2016-2020 (USD/Pcs)
Table Global Spinal Muscular Atrophy Medicine Sales by Application (2016-2020) (K Pcs)
Table Global Spinal Muscular Atrophy Medicine Sales Share by Application (2016-2020)
Figure Global Sales Spinal Muscular Atrophy Medicine Market Share by Application (2016-2020)
Figure Global Sales Spinal Muscular Atrophy Medicine Market Share by Application (2016-2020)
Figure United States Spinal Muscular Atrophy Medicine Sales Growth Rate 2016-2020 (K Pcs)
Figure United States Spinal Muscular Atrophy Medicine Revenue Growth Rate 2016-2020 (Million US$)
Table United States Spinal Muscular Atrophy Medicine Sales by Company (2016-2020) (K Pcs)
Table United States Spinal Muscular Atrophy Medicine Sales Market Share by Company (2016-2020)
Figure United States Spinal Muscular Atrophy Medicine Sales Market Share by Company in 2020
Table United States Spinal Muscular Atrophy Medicine Sales by Type (2016-2020) (K Pcs)
Table United States Spinal Muscular Atrophy Medicine Sales Market Share by Type (2016-2020)
Figure United States Spinal Muscular Atrophy Medicine Market Share by Type in 2020
Table United States Spinal Muscular Atrophy Medicine Sales by Application (2016-2020) (K Pcs)
Table United States Spinal Muscular Atrophy Medicine Sales Market Share by Application (2016-2020)
Figure United States Spinal Muscular Atrophy Medicine Market Share by Application in 2020
Figure European Union Spinal Muscular Atrophy Medicine Sales Growth Rate 2016-2020 (K Pcs)
Figure European Union Spinal Muscular Atrophy Medicine Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Spinal Muscular Atrophy Medicine Sales by Company (2016-2020) (K Pcs)
Table European Union Spinal Muscular Atrophy Medicine Sales Market Share by Company (2016-2020)
Figure European Union Spinal Muscular Atrophy Medicine Sales Market Share by Company in 2020
Table European Union Spinal Muscular Atrophy Medicine Sales by Type (2016-2020) (K Pcs)
Table European Union Spinal Muscular Atrophy Medicine Sales Market Share by Type (2016-2020)
Figure 2020 European Union Spinal Muscular Atrophy Medicine Market Share by Type
Table European Union Spinal Muscular Atrophy Medicine Sales by Application (2016-2020) (K Pcs)
Table European Union Spinal Muscular Atrophy Medicine Sales Market Share by Application (2016-2020)
Figure 2020 European Union Spinal Muscular Atrophy Medicine Market Share by Application
Figure China Spinal Muscular Atrophy Medicine Sales Growth Rate 2016-2020 (K Pcs)
Figure China Spinal Muscular Atrophy Medicine Revenue Growth Rate 2016-2020 (Million US$)
Table China Spinal Muscular Atrophy Medicine Sales by Company (2016-2020) (K Pcs)
Table China Spinal Muscular Atrophy Medicine Sales Market Share by Company (2016-2020)
Figure China Spinal Muscular Atrophy Medicine Sales Market Share by Company in 2020
Table China Spinal Muscular Atrophy Medicine Sales by Type (2016-2020) (K Pcs)
Table China Spinal Muscular Atrophy Medicine Sales Market Share by Type (2016-2020)
Figure China Spinal Muscular Atrophy Medicine Market Share by Type in 2020
Table China Spinal Muscular Atrophy Medicine Sales by Application (2016-2020) (K Pcs)
Table China Spinal Muscular Atrophy Medicine Sales Market Share by Application (2016-2020)
Figure China Spinal Muscular Atrophy Medicine Market Share by Application in 2020
Figure Rest of World Spinal Muscular Atrophy Medicine Sales Growth Rate 2016-2020 (K Pcs)
Figure Rest of World Spinal Muscular Atrophy Medicine Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Spinal Muscular Atrophy Medicine Sales by Company (2016-2020) (K Pcs)
Table Rest of World Spinal Muscular Atrophy Medicine Sales Market Share by Company (2016-2020)
Figure Rest of World Spinal Muscular Atrophy Medicine Sales Market Share by Company in 2020
Table Rest of World Spinal Muscular Atrophy Medicine Sales by Type (2016-2020) (K Pcs)
Table Rest of World Spinal Muscular Atrophy Medicine Sales Market Share by Type (2016-2020)
Figure Rest of World Spinal Muscular Atrophy Medicine Market Share by Type in 2020
Table Rest of World Spinal Muscular Atrophy Medicine Sales by Application (2016-2020) (K Pcs)
Table Rest of World Spinal Muscular Atrophy Medicine Sales Market Share by Application (2016-2020)
Figure Rest of World Spinal Muscular Atrophy Medicine Market Share by Application in 2020
Table Rest of World Spinal Muscular Atrophy Medicine Sales by Countries (2016-2020) (K Pcs)
Table Rest of World Spinal Muscular Atrophy Medicine Sales Market Share by Countries (2016-2020)
Figure Rest of World Spinal Muscular Atrophy Medicine Sales Market Share by Countries in 2020
Table Rest of World Spinal Muscular Atrophy Medicine Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Spinal Muscular Atrophy Medicine Revenue Market Share by Countries (2016-2020)
Figure Rest of World Spinal Muscular Atrophy Medicine Revenue Market Share by Countries in 2020
Figure Japan Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020) (K Pcs)
Figure Japan Spinal Muscular Atrophy Medicine Revenue Growth Rate (2016-2020) (K Pcs)
Figure Korea Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020) (K Pcs)
Figure Korea Spinal Muscular Atrophy Medicine Revenue Growth Rate (2016-2020) (K Pcs)
Figure India Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020) (K Pcs)
Figure India Spinal Muscular Atrophy Medicine Revenue Growth Rate (2016-2020) (K Pcs)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020) (K Pcs)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue Growth Rate (2016-2020) (K Pcs)
Table Astellas Pharma Inc. Company Details
Table Astellas Pharma Inc. Description and Business Overview
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table Astellas Pharma Inc. Recent Development
Table AveXis, Inc. Company Details
Table AveXis, Inc. Description and Business Overview
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table AveXis, Inc. Recent Development
Table Bioblast Pharma Ltd. Company Details
Table Bioblast Pharma Ltd. Description and Business Overview
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table Bioblast Pharma Ltd. Recent Development
Table Cytokinetics, Inc. 24 Company Details
Table Cytokinetics, Inc. 24 Description and Business Overview
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table Cytokinetics, Inc. 24 Recent Development
Table F. Hoffmann-La Roche Ltd. Company Details
Table F. Hoffmann-La Roche Ltd. Description and Business Overview
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Genethon Company Details
Table Genethon Description and Business Overview
Table Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Genethon Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table Genethon Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table Genethon Recent Development
Table Genzyme Corporation Company Details
Table Genzyme Corporation Description and Business Overview
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table Genzyme Corporation Recent Development
Table GMP-Orphan SAS Company Details
Table GMP-Orphan SAS Description and Business Overview
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table GMP-Orphan SAS Recent Development
Table Ionis Pharmaceuticals, Inc. Company Details
Table Ionis Pharmaceuticals, Inc. Description and Business Overview
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table Ionis Pharmaceuticals, Inc. Recent Development
Table Longevity Biotech, Inc Company Details
Table Longevity Biotech, Inc Description and Business Overview
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2020)
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales Growth Rate (2016-2020)
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales Market Share in Global Market
Table Longevity Biotech, Inc Recent Development
Table Neurodyn Inc. Company Details
Table Neurotune AG Company Details
Table Novartis AG Company Details
Table Sarepta Therapeutics, Inc. Company Details
Table Voyager Therapeutics, Inc. Company Details
Table Vybion, Inc. Company Details
Table WAVE Life Sciences Ltd. Company Details
Figure Spinal Muscular Atrophy Medicine Value Chain
Table Spinal Muscular Atrophy Medicine Distributors List
Table Spinal Muscular Atrophy Medicine Customers List
Table Global Spinal Muscular Atrophy Medicine Sales Forecast 2021-2027 (K Pcs) & (Million US$)
Figure Global Spinal Muscular Atrophy Medicine Sales Forecast 2021-2027 (K Pcs)
Figure Global Spinal Muscular Atrophy Medicine Revenue Forecast 2021-2027 (Million US$)
Table Global Spinal Muscular Atrophy Medicine Sales Forecast by Type 2021-2027 (K Pcs)
Figure Global Spinal Muscular Atrophy Medicine Sales Forecast by Type 2021-2027 (K Pcs)
Figure Global Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Type 2021-2027
Table Global Spinal Muscular Atrophy Medicine Sales Forecast by Application 2021-2027 (K Pcs)
Figure Global Spinal Muscular Atrophy Medicine Sales Forecast by Application 2021-2027 (K Pcs)
Figure Global Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Application 2021-2027
Table Global Spinal Muscular Atrophy Medicine Sales Forecast by Regions 2021-2027 (K Pcs)
Figure Global Spinal Muscular Atrophy Medicine Sales Forecast by Regions 2021-2027 (K Pcs)
Figure Global Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Regions 2021-2027
Table Global Spinal Muscular Atrophy Medicine Revenue Forecast by Regions 2021-2027 (K Pcs)
Figure Global Spinal Muscular Atrophy Medicine Revenue Forecast by Regions 2021-2027 (K Pcs)
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Regions 2021-2027
Figure United States Spinal Muscular Atrophy Medicine Sales Forecast 2021-2027 (K Pcs)
Figure United States Spinal Muscular Atrophy Medicine Revenue Forecast 2021-2027 (Million US$)
Figure European Union Spinal Muscular Atrophy Medicine Sales Forecast 2021-2027 (K Pcs)
Figure European Union Spinal Muscular Atrophy Medicine Revenue Forecast 2021-2027 (Million US$)
Figure China Spinal Muscular Atrophy Medicine Sales Forecast 2021-2027 (K Pcs)
Figure China Spinal Muscular Atrophy Medicine Revenue Forecast 2021-2027 (Million US$)
Figure Japan Spinal Muscular Atrophy Medicine Sales Forecast 2021-2027 (K Pcs)
Figure Japan Spinal Muscular Atrophy Medicine Revenue Forecast 2021-2027 (Million US$)
Figure Korea Spinal Muscular Atrophy Medicine Sales Forecast 2021-2027 (K Pcs)
Figure Korea Spinal Muscular Atrophy Medicine Revenue Forecast 2021-2027 (Million US$)
Figure India Spinal Muscular Atrophy Medicine Sales Forecast 2021-2027 (K Pcs)
Figure India Spinal Muscular Atrophy Medicine Revenue Forecast 2021-2027 (Million US$)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Forecast 2021-2027 (K Pcs)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue Forecast 2021-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources